Decreased plasma concentration of brain natriuretic peptide as a potential indicator of cardiac recovery in patients supported by mechanical circulatory assist systems

Journal of the American College of Cardiology

Volumn 38, Issue 7, 2001, Pages 1942-1949

  Sodian, Ralf ^a   Loebe, Matthias ^a,b   Schmitt, Christoph ^a   Potapov, Evgenij V ^a   Siniawski, Henryk ^a   Müller, Johannes ^a   Hausmann, Harald ^a   Zurbruegg, Heinz R ^a   Weng, Yuguo ^a   Hetzer, Roland ^a  

^a DEUTSCHES HERZZENTRUM BERLIN   (Germany)

^b BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BRAIN NATRIURETIC PEPTIDE;

ADOLESCENT; ADULT; ARTICLE; ASSISTED CIRCULATION; BLOOD LEVEL; CONTROLLED STUDY; CONVALESCENCE; CORRELATION FUNCTION; HEART FAILURE; HUMAN; PRESCHOOL CHILD; PRIORITY JOURNAL; SURVIVAL RATE;

ADOLESCENT; ADULT; CHILD, PRESCHOOL; ECHOCARDIOGRAPHY, TRANSESOPHAGEAL; FEMALE; HEART FAILURE, CONGESTIVE; HEART-ASSIST DEVICES; HUMANS; MALE; MIDDLE AGED; NATRIURETIC PEPTIDE, BRAIN; PREDICTIVE VALUE OF TESTS; PROGNOSIS; SURVIVAL RATE;

EID: 0035204653     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0735-1097(01)01677-1     Document Type: Article

References (32)

1. Successful management of acute myocarditis with biventricular assist devices and cardiac transplantation
2. Weaning from mechanical cardiac support in patients with idiopathic dilated cardiomyopathy
3. Improved survival in patients with acute myocarditis using external pulsatile mechanical ventricular assistance
4. Structural and left ventricular histologic changes after implantable LVAD insertion
5. Midterm follow-up of patients who underwent removal of a left ventricular assist device after cardiac recovery from end-stage dilated cardiomyopathy
6. Improved mortality and rehabilitation of transplant candidates treated with a long-term implantable left ventricular assist system
7. Ventricular assistance for recovery of cardiac failure
8. Atrial natriuretic peptide elevation in congestive heart failure in the human
9. Natriuretic peptides
10. Localization and mechanism of secretion of B-type natriuretic peptide in comparison with those of A-type natriuretic peptide in normal subjects and patients with heart failure
11. Device selection in mechanical circulatory support
12. A rapid and potent natriuretic response to intravenous injection of atrial myocardial extract in rats
13. Implantable left ventricular assist devices
14. Cardiac recovery in dilated cardiomyopathy by unloading with a left ventricular assist device
15. Transient normalization of systolic and diastolic function after support with a left ventricular assist device in a patient with dilated cardiomyopathy
16. Tumor necrosis factor-alpha and tumor necrosis factor receptors in the failing human heart
17. Regression of cellular hypertrophy after left ventricular assist device support
18. Neurohormonal changes after implantation of a left ventricular assist system
19. Improved left ventricular function after chronic left ventricular unloading
20. +)-ATPase in failing and nonfailing human hearts
21. Plasma brain natriuretic peptide as an indicator for angiotensin-converting-enzyme inhibition after myocardial infarction
22. Value of natriuretic peptides in assessment of patients with possible new heart failure in primary care
23. Plasma brain natriuretic peptide as a biochemical marker of high left ventricular end-diastolic pressure in patients with symptomatic left ventricular dysfunction
24. Sympathoinhibitory effects of atrial natriuretic peptide in rats with heart failure
25. Pathophysiologically relevant concentrations of tumor necrosis factor-alpha promote progressive left ventricular dysfunction and remodeling in rats
26. Structural and left ventricular histologic changes after implantable LVAD insertion
27. Myocyte recovery after mechanical circulatory support in humans with end-stage heart failure
28. Effect of spironolactone on plasma brain natriuretic peptide and left ventricular remodeling in patients with congestive heart failure
29. Effects of intravenous brain natriuretic peptide on regional sympathetic activity in patients with chronic heart failure as compared with healthy control subjects
30. Myocardial recovery after mechanical support for acute myocarditis: Is sustained recovery predictable?
31. MEDOS HIA-VAD biventricular assist device for bridge to recovery in fulminant myocarditis